Canada
will not appeal ruling allowing patients to grow own pot
Send a link to a friend
[March 25, 2016]
By Julie Gordon
VANCOUVER (Reuters) - Medical marijuana
patients in Canada will regain the right to grow their own cannabis
after the government said on Thursday it would comply with a federal
court decision against a ban introduced by the previous Conservative
government.
|
The federal government said Canada's medical marijuana laws would be
rewritten to reflect the court's judgment, setting a deadline of
Aug. 24 to finalize the changes.
"We are committed, as you know, to making sure that Canadians who
require marijuana for medical purposes have appropriate access to
that," Health Minister Jane Philpott told reporters in Ottawa,
adding that the current law will remain in place until the changes
are finalized.
Philpott did not provide specifics on the planned amendments, but
noted the government was focused on addressing the issues of
accessibility and affordability.
In 2013, the then-ruling Conservative government overhauled Canada's
medical marijuana program, requiring that patients buy their
cannabis from licensed producers through a mail order system,
instead of growing their own marijuana.
That prompted a group of British Columbia residents to take Canada
to court over the ban, which they said was unconstitutional. Last
month, a federal court judge in Vancouver agreed with them, striking
down the ban.
Medical marijuana is a separate issue from recreational marijuana in
Canada. The Liberals, who vaulted to power in October, have pledged
to legalize and regulate the recreational use of cannabis, though
the time frame remains unclear.
[to top of second column] |
Shares of medical marijuana producers were mixed on Thursday, with
Canopy Growth Co closing up 2.36 percent at C$2.60, OrganiGram
Holdings flat at 76 Canadian cents and Aphria Inc down 1.29 percent
to 77 Canadian cents.
(Additional reporting by David Ljunggren in Ottawa; Editing by Dan
Grebler)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|